How to use the speech recognition tool?

NCT02303288

Argus® II Retinal Prosthesis System: Post-Market Study

Argus® II Retinal Prosthesis System: Post-Market Study

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2016-05-12
  • Closing Date: 2026-05-12

Criteria

Inclusion: Adults at least 25 years old; Suffering from retinitis pigmentosa with visual acuity of the order of perception of light or less in both eyes; Having had a vision of useful forms in the past; If there is no residual perception of the light, the retina mus

More information

Children: No

Adults: Yes

Funder Type: industry


Within ERN-EYE members

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: